By Reportstack.com
Published: Wednesday, Sep. 12, 2012
NEW YORK, LONDON, BERLIN and PARIS, September 12, 2012 -- /PRNewswire/ --
In a new report titled 'Healthcare, Regulatory and Reimbursement Landscape in Mexico', industry analyst estimate that the pharmaceuticals market in Mexico will reach approximately $22.5 billion by 2020 at a projected CAGR of 7%. This new report is an essential source of information and analysis on the Mexican healthcare, regulatory and reimbursement landscape as this report identifies the key trends in the Mexican healthcare market, as well as providing insights on the demographic, regulatory, and reimbursement landscape, and the healthcare infrastructure of Mexico.
The population of Mexico in 2010 was approximately 112 million and was the 11th most populated country in the world, and is increasing due to the country's high birth rate and increase in life expectancy. The pharmaceutical market in Mexico was estimated at $11.4 billion in 2010. The medical device market size was approximately $3 billion in 2010 and is expected to reach approximately $4.9 billion by 2020 at a projected CAGR of 5.2%.
The positive trend in the Mexican healthcare market can be attributed primarily to -
- Increasing elderly population
- Government initiatives for the prevention and management of chronic diseases
- The North American Free Trade Agreement, which guarantees its members the protection of intellectual property rights
- An improved and updated regulatory environment
No comments:
Post a Comment